News articles

News article list

• NICE is getting ready for the end of the transition period after Brexit

  NICE has a key role in ensuring the UK remains a destination of choice for the life sciences sector.

• NICE recommends innovative treatment for severe blood disorder for NHS use

  Caplacizumab, with plasma exchange and immunosuppression, will be used to treat acute acquired thrombotic thrombocytopenic purpura.

• NICE recommends new chemotherapy-free treatment option for people with untreated chronic lymphocytic leukaemia

  More than 1,000 people each year will benefit from NICE's recommendation.

• NICE guidance addresses the best approach to the diagnosis and management of ME/CFS

  NICE has today (10 November 2020) published its draft guideline on the diagnosis and management of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).

• NICE to become single point of access for Covid-19 guidance and advice

  NICE announced that it is to host a new, single point of advice on caring for people with Covid-19 and the management of Covid-19 in a variety of clinical settings.

• New treatment option for adults with obesity and non-diabetic hyperglycaemia

  All eligibility criteria must be met for Liraglutide to be offered.